Related Experiment Video
Updated: Jun 30, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Oral histoplasmosis: an unusual presentation
Nagamani Narayana1, Ryan Gifford, Peter Giannini
1Department of Oral Biology, UNMC College of Dentistry, 40th and Holdrege streets, Lincoln, Nebraska 68583, USA. nnarayana@unmc.edu
Background:
Histoplasmosis is a localized or systemic fungal infection which may present as an acute primary or "reactivation" infection in the setting of immunosuppression. Tumor necrosis factor alpha (TNF-alpha) antagonists, used in the management of rheumatoid arthritis and Crohn disease, have been linked to reactivation of quiescent histoplasmosis. Microscopically, granulomas are either not evident or are infrequent in histoplasmosis when associated with TNF antagonist therapy presumably due to the suppression of macrophage activity.
Methods And Results:
This article describes an unusual presentation of oral histoplasmosis in a 75-year-old-woman patient on TNF-alpha antagonist, namely infliximab. Microscopically, cellular atypia resulted in a work-up to rule out lymphoma. Gomori's methenamine silver stain demonstrated Histoplasma capsulatum leading to a diagnosis of histoplasmosis. She was treated successfully with itraconozole.
Conclusion:
This is the first reported case, insofar as the authors are able to determine, of oral histoplasmosis, in a patient undergoing treatment with infliximab.
Insights
This case study reports the first instance of oral histoplasmosis in a patient using infliximab, a TNF-alpha antagonist. Treatment with itraconazole was successful, highlighting a rare complication of immunosuppressive therapy.
Area of Science:
- Mycology
- Immunology
- Gastroenterology
Background:
- Histoplasmosis is a fungal infection that can reactivate in immunosuppressed individuals.
- Tumor necrosis factor alpha (TNF-alpha) antagonists, used for autoimmune conditions, are associated with histoplasmosis reactivation.
- Granuloma formation is often suppressed in TNF-alpha antagonist-associated histoplasmosis.
Observation:
- A 75-year-old woman on infliximab presented with an unusual oral histoplasmosis.
- Microscopic examination revealed cellular atypia, prompting a lymphoma work-up.
- Gomori's methenamine silver stain confirmed Histoplasma capsulatum.
Findings:
- The patient was diagnosed with oral histoplasmosis.
- The condition was successfully treated with itraconazole.
- This represents the first reported case of oral histoplasmosis in an infliximab patient.
Implications:
- Highlights a rare oral manifestation of histoplasmosis in patients on TNF-alpha antagonists.
- Underscores the importance of considering opportunistic infections in immunosuppressed patients.
- Suggests careful monitoring for atypical presentations in patients receiving TNF-alpha inhibitors.
Related Concept Videos
Toxoplasmosis
Amebiasis
Atypical Pneumonia
Cryptococcal Meningitis
Leishmaniasis
Cytomegalovirus Disease